1-3 of 3
Annelise Notenboom
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Intensified 12-week CHOP (I-CHOP) plus G-CSF compared with standard 24-week CHOP (CHOP-21) for patients with intermediate-risk aggressive non-Hodgkin lymphoma: a phase 3 trial of the Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON)

Clinical Trials & Observations
Leo F. Verdonck, Annelise Notenboom, Daphne D. de Jong, Marius A. MacKenzie, Gregor E. G. Verhoef, Mark H. H. Kramer, Gert J. Ossenkoppele, Jeanette K. Doorduijn, Pieter Sonneveld, Gustaaf W. van Imhoff
Journal: Blood
Blood (2006) 109 (7): 2759–2766.
https://doi.org/10.1182/blood-2006-07-035709
Published: 2006
Includes: Supplemental data
Journal Articles

Rituximab (Mabthera) Improves the Treatment Results of DHAP-VIM-DHAP and ASCT in Relapsed/Progressive Aggressive CD20 + NHL. A Prospective Randomized HOVON Trial.

Edo Vellenga, MD, PhD, Annelise Notenboom, PhD, Mars van ‘t Veer, MDPhD, Josée Zijlstra, MD, Willem E. Fibbe, MDPhD, Rien van Oers, MDPhD, Gustaaf W. van Imhoff, MDPhD, Elly Lugtenburg, MDPhD, P.C. Huijgens, MDPhD
Journal: Blood
Blood (2006) 108 (11): 328.
https://doi.org/10.1182/blood.V108.11.328.328
Published: 2006
Journal Articles

First Report of the HOVON 45: A Phase II Study with Rituximab, High Dose Ara-C and Autologous Stem Cell Transplantation in the Primary Treatment of Mantle Cell Lymphoma.

Mars B. Van’t Veer, MD, PhD, Annelise Notenboom, PhD, Marius McKenzie, MD,PhD, Hanneke Kluin-Nelemans, MD,PhD, Rien van Oers, MD,PhD, Jose Zijlstra, MD, Daphne de Jong, MD,PhD, Pieter Sonneveld, MD,PhD, Anton Hagenbeek, MD,PhD
Journal: Blood
Blood (2006) 108 (11): 2734.
https://doi.org/10.1182/blood.V108.11.2734.2734
Published: 2006